ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 65 filers reported holding ATRECA INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,442 | -73.4% | 59,168 | 0.0% | 0.00% | – |
Q2 2023 | $57,985 | -20.3% | 59,168 | -7.3% | 0.00% | – |
Q1 2023 | $72,786 | +54.5% | 63,847 | +8.5% | 0.00% | – |
Q4 2022 | $47,100 | -52.9% | 58,831 | -7.6% | 0.00% | – |
Q3 2022 | $100,000 | -4.8% | 63,654 | +8.2% | 0.00% | – |
Q2 2022 | $105,000 | -85.5% | 58,831 | -74.3% | 0.00% | – |
Q1 2022 | $726,000 | -3.8% | 229,226 | -8.0% | 0.00% | – |
Q4 2021 | $755,000 | -53.0% | 249,074 | -3.4% | 0.00% | – |
Q3 2021 | $1,606,000 | -30.0% | 257,922 | -4.2% | 0.00% | – |
Q2 2021 | $2,294,000 | -54.0% | 269,255 | -17.2% | 0.00% | -100.0% |
Q1 2021 | $4,986,000 | -10.6% | 325,302 | -5.8% | 0.00% | 0.0% |
Q4 2020 | $5,577,000 | +15.2% | 345,272 | -0.3% | 0.00% | 0.0% |
Q3 2020 | $4,840,000 | -11.5% | 346,397 | +34.9% | 0.00% | 0.0% |
Q2 2020 | $5,466,000 | +80.9% | 256,838 | +40.7% | 0.00% | 0.0% |
Q1 2020 | $3,022,000 | +155.7% | 182,599 | +139.0% | 0.00% | – |
Q4 2019 | $1,182,000 | +20.6% | 76,391 | -4.6% | 0.00% | – |
Q3 2019 | $980,000 | – | 80,062 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,320,880 | $2,100,000 | 1.66% |
CM Management, LLC | 249,282 | $391,000 | 0.44% |
Aisling Capital Management LP | 387,653 | $609,000 | 0.40% |
Boxer Capital, LLC | 2,202,333 | $3,458,000 | 0.19% |
Samsara BioCapital, LLC | 396,835 | $623,000 | 0.14% |
Redmile Group, LLC | 800,306 | $1,256,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 191,442 | $301,000 | 0.04% |
Baker Brothers Advisors | 3,532,760 | $5,546,000 | 0.04% |
Cormorant Asset Management, LP | 319,057 | $501,000 | 0.04% |
Rock Springs Capital Management LP | 462,530 | $726,000 | 0.02% |